BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Popova SN, Tarvainen I, Capellari S, Parchi P, Hannikainen P, Pirinen E, Haapasalo H, Alafuzoff I. Divergent clinical and neuropathological phenotype in a Gerstmann-Sträussler-Scheinker P102L family. Acta Neurol Scand 2012;126:315-23. [PMID: 22211828 DOI: 10.1111/j.1600-0404.2011.01628.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Pal S, Udgaonkar JB. Evolutionarily Conserved Proline Residues Impede the Misfolding of the Mouse Prion Protein by Destabilizing an Aggregation-competent Partially Unfolded Form. Journal of Molecular Biology 2022;434:167854. [DOI: 10.1016/j.jmb.2022.167854] [Reference Citation Analysis]
2 Eraña H, San Millán B, Díaz-Domínguez CM, Charco JM, Rodríguez R, Viéitez I, Pereda A, Yañez R, Geijo M, Navarro C, Perez de Nanclares G, Teijeira S, Castilla J. Description of the first Spanish case of Gerstmann-Sträussler-Scheinker disease with A117V variant: clinical, histopathological and biochemical characterization. J Neurol 2022. [PMID: 35294616 DOI: 10.1007/s00415-022-11051-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Tesar A, Matej R, Kukal J, Johanidesova S, Rektorova I, Vyhnalek M, Keller J, Eliasova I, Parobkova E, Smetakova M, Musova Z, Rusina R. Clinical Variability in P102L Gerstmann-Sträussler-Scheinker Syndrome. Ann Neurol 2019;86:643-52. [PMID: 31397917 DOI: 10.1002/ana.25579] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
4 Ishizawa K, Mitsufuji T, Shioda K, Kobayashi A, Komori T, Nakazato Y, Kitamoto T, Araki N, Yamamoto T, Sasaki A. An autopsy report of three kindred in a Gerstmann-Sträussler-Scheinker disease P105L family with a special reference to prion protein, tau, and beta-amyloid. Brain Behav 2018;8:e01117. [PMID: 30240140 DOI: 10.1002/brb3.1117] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
5 Takada LT, Kim M, Metcalf S, Gala II, Geschwind MD. Prion disease. Neurogenetics, Part II. Elsevier; 2018. pp. 441-64. [DOI: 10.1016/b978-0-444-64076-5.00029-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
6 Atkinson CJ, Zhang K, Munn AL, Wiegmans A, Wei MQ. Prion protein scrapie and the normal cellular prion protein. Prion 2016;10:63-82. [PMID: 26645475 DOI: 10.1080/19336896.2015.1110293] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
7 Dong Y, Chen S, Liu Z, Lu C, Gan S. Cerebellar Ataxia. Inherited Neurological Disorders 2017. [DOI: 10.1007/978-981-10-4196-9_1] [Reference Citation Analysis]
8 Li HF, Liu ZJ, Dong HL, Xie JJ, Zhao SY, Ni W, Dong Y, Wu ZY. Clinical features of Chinese patients with Gerstmann-Sträussler-Scheinker identified by targeted next-generation sequencing. Neurobiol Aging 2017;49:216.e1-5. [PMID: 28340953 DOI: 10.1016/j.neurobiolaging.2016.09.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
9 Asante EA, Grimshaw A, Smidak M, Jakubcova T, Tomlinson A, Jeelani A, Hamdan S, Powell C, Joiner S, Linehan JM, Brandner S, Wadsworth JD, Collinge J. Transmission Properties of Human PrP 102L Prions Challenge the Relevance of Mouse Models of GSS. PLoS Pathog 2015;11:e1004953. [PMID: 26135918 DOI: 10.1371/journal.ppat.1004953] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
10 Higuma M, Sanjo N, Satoh K, Shiga Y, Sakai K, Nozaki I, Hamaguchi T, Nakamura Y, Kitamoto T, Shirabe S, Murayama S, Yamada M, Tateishi J, Mizusawa H. Relationships between clinicopathological features and cerebrospinal fluid biomarkers in Japanese patients with genetic prion diseases. PLoS One 2013;8:e60003. [PMID: 23555862 DOI: 10.1371/journal.pone.0060003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
11 Sano K, Satoh K, Atarashi R, Takashima H, Iwasaki Y, Yoshida M, Sanjo N, Murai H, Mizusawa H, Schmitz M, Zerr I, Kim YS, Nishida N. Early detection of abnormal prion protein in genetic human prion diseases now possible using real-time QUIC assay. PLoS One 2013;8:e54915. [PMID: 23372790 DOI: 10.1371/journal.pone.0054915] [Cited by in Crossref: 103] [Cited by in F6Publishing: 108] [Article Influence: 11.4] [Reference Citation Analysis]